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To establish a baseline of knowledge regarding about inappropriate therapy, virulence and 
resistance in a cohort of patients infected with S. aureus. Retrospective cohort study in 
tertiary-care university hospital was employed to evaluate the risk factors and the impact of 
inappropriate therapy among patients with Staphylococcus aureus infections, resistance and 
virulence. To assess the presence of the genes was performed PCR. Patients with MRSA were 
older and hospitalized 17 days longer than those with MSSA infection, which were in ICU 
with a bloodstream infection. 50.0% received inappropriate antibiotic therapy and we found 
virulence factors associated with MRSA (mecA, LukS, fnbB and clfA genes). These data show 
that monitoring studies related to Staphylococcus aureus infections remain essential to identify 
resistance and inform policy on resistance. 
Explorando o staphylococcus aureus em pacientes infectados em um hopital 
universitário terciário: resultados de um estudo de coorte retrospectivo
Estabelecer uma linha de base de conhecimentos sobre terapia inadequada, virulência e r 
esistência em uma coorte de pacientes infectados com S. aureus. Estudo de coorte retrospec-
tivo em hospital universitário de atendimento terciário foi empregado para avaliar os fatores 
de risco e o impacto da terapia inadequada entre pacientes com infecções por Staphylococcus 
aureus, resistência e virulência. Para avaliar a presença dos genes foi realizado PCR. Pacientes 
com MRSA eram mais velhos e hospitalizados 17 dias a mais do que aqueles com infecção por 
MSSA, que estavam em UTI com infecção na corrente sanguínea. 50,0% receberam antibioti-
coterapia inadequada e encontramos fatores de virulência associados ao MRSA (genes mecA, 
LukS, fnbB e clfA). Esses dados mostram que os estudos de vigilância relacionados às infecções 
por Staphylococcus aureus permanecem essenciais para identificar a resistência e informar as 
políticas sobre resistência.
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Introduction
The epidemiology of Staphylococcus aureus is dynamic and has been presenting significant changes in 
recent years (OLIVEIRA; FARIA; LEVYAND, et al. 2001; AÑÓN; RODRÍGUEZ; TINAJAS, et al. 2004; 
PARKER, 2017; KOECH; COMO-SABETTI; BOXRUDE, 2019). Although Gram-negative bacteria are 
the most common source of nosocomial infections, S. aureus infections are still a substantial source of 
morbidity and mortality because they have the ability to induce inflammation and are responsible for 
superficial and invasive infections PELEG; HOOPER, 2010; SCHWEIZER.; EBER; LAXMINARAYAN, 
et al. 2011).
The treatment of infections caused by this microorganism is complicated by the high prevalence of 
multidrug-resistant strains, selected by the indiscriminate and inappropriate use of antibiotic, mainly 
associated with horizontal transfer of genes of resistance (HEGGERNDORNN; GOMES; SILVA, et al. 
2016). 
S. aureus still presents an arsenal of virulence factors that contribute to its survival and development, and 
it is responsible for the onset of clinical manifestations and severity of infections RICARDO-CALDERA; 
BUELVAS-DORIA; ESCOBAR-PÉREZ, et al. 2015).  Although resistance plays an important role in the 
worsening of these infections, the pathogenic capacity of this microorganism is the result of the combined 
effect of the production of virulence factors, such as enzymes and toxins, and the ability to form biofilm, 
multiplication and dissemination in tissues and organs, besides its invasive capacity (CHAMBERS; 
DELEO, 2009; STEFANI; GOGLIO, 2010; BIMANAND, L.; TAHERIKALANI; JALILIAN, et al. 2018).
Reports of methicillin-resistant Staphylococcus aureus (MRSA) emerged in the 1960s, and currently, 
MRSA isolates are estimated with a prevalence of 25 of 50% or more in some hospitalization areas 
(INDRAWATTANA; SUNGKHACHAT; SOOKRUNG, et al. 2013; SANTAJIT; INDRAWATTANA, 
2016). In recent years, due to the increased rate of detection of MRSA, empirical antibiotic treatment 
has become even more difficult, additionally, when the prescription occurs inappropriately, there is an 
increase in hospital stay, treatment costs and risk of death (PAUL; SHANI; MUCHTAR, et al. 2010; WEISS; 
FITZGERALD; BALAMUTH, et al. 2014; ZHANG; MICEK; KOLLEF, 2015; LI; LI; ZHANG, et al. 2019).
We aim to establish a baseline of knowledge regarding about inappropriate therapy, virulence and 
resistance in a cohort of patients infected with S. aureus.
Materials and methods 
Patients, settings and study design
The data base at our clinical microbiology laboratory was reviewed to identify patients with 
Staphylococcus aureus infections from November/2015 to April/2016 at Uberlandia University Hospital 
(Brazil), a 533-bed tertiary-care university hospital. For comparison between patients with Methicillin-
resistant Staphylococcus aureus (MRSA) and methicillin-susceptible Staphylococcus aureus (MSSA), only 
the first episode was analyzed.  
A retrospective cohort study was employed to evaluate the risk factors and the impact of inappropriate 
therapy among patients with Staphylococcus aureus infections. During the surveillance period, 80 episodes 
of S. aureus infection were recovered from 55 patients. The main outcome was in hospital mortality and 
the procedure also assessed secondary outcomes, including the duration of hospital stays, admission to 
the Intensive Care Unit (ICU) and the use of central venous catheter and mechanical ventilation.
The data and the samples analyzed in the present study were obtained in accordance with the norms 
and approved by the Federal University of Uberlandia Ethics Committee (UFU), through license number 
36601814.7.0000.5152 and 60374516.6.0000.5152. 
Definitions
Hospital infection is acquired after the admission of the patient and it is manifested during hospitalization 
or after discharge, when it may be related to the hospitalization or hospital procedures (BRASIL, 1998). 
Inappropriate empirical therapy is the antimicrobial treatment with agents that did not have "in vitro" 
activity and/or treatment performed over 48 hours (DAIKOS; TSAOUSI; TZOUVELEKIS, et al. 2010). 
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Hospital mortality is an evolution of patient’s condition to death in 30 days after diagnosis of infection 
(LODISE; PATEL; KWA, et al. 2007).  
Identification of species, antimicrobial susceptibility and molecular testing
Microbial identification and antimicrobial susceptibility testing were performed on a VITEK®II 
automated system (bioMérieux). To assess the presence of the mecA gene, LukS gene, fnbB and clfA 
genes in Staphylococcus aureus strains, a polymerase chain reaction (PCR) was performed, as described 
previously by Kondo et al. (2007), Said Salim et al. (2005) and Tristan et al. (2003), respectively. All PCRs 
were carried in a mastercycler personal (Eppendorf). To perform the PCR, only 38.8% of the isolates 
were chosen, due to the costs of molecular techniques. The criteria for selecting these were based on the 
antibiogram as follows: samples with the highest resistance profiles (in the cases of groups R1 and R2) 
and samples only with resistance to methicillin (in the case of group R3)
Statistical analysis 
The evaluate of quantitative variables were performed by Student’s T-Test. Categorical variables were 
expressed as mean and standard deviation. The statistical significance was defined by a value of P ≥ 0,05, 
using the statistical program GraphPad Prism 5.01.
Results and Discussion
Fifty-five patients (147 episodes with infection) were selected hospital-wide during surveillance period, 
S. aureus was the most common species (54.4%), of which 29.9% were oxacillin resistant followed by 
Gram-negative bacilli (38.8%). Most of this isolated (32.6%) were detected from patients on the ICU. 
A predominance of bloodstream infection (40.9%) among MRSA, and pneumonia (33.3% and 31.5%, 
respectively) among MSSA and Gram-negative bacilli was observed (Table 1).
Table 1- Episodes of hospital bacterial infection from November/2015 and April/2016 second according 
to isolation site and clinic/ sector.
¹Staphylococcus haemoyticus, Staphylococcus hominis, Staphylococcuss aprophyticus, Staphylococcus epidermidis, Staphylo-
coccus caprae, Streptococcus pyogenes, Streptococcus spp.
²Stenotrophomonas maltophilia, Serratia marcenes, Klebsiella pneumoniae, Pseudomonas aeruginosa, Acinetobacter bau-
mannii
3Eyes, soft parts, bone
4Intensive-care unit
5Emergency room, pediatric, nursery, gynecology and obstetrics
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Based on the antibiotic susceptibility test, 11 antibiotypes (R1-R11) were identified among isolates of Staphylococcus 
aureus. The most isolated were assigned antibiotype R2 (30.0%) and R1 (18.7%). In R2 strains presented predominantly 
the genotype mecA+/ PVL-/ clfA+/ fnbB- (29.1%), with more isolates in lung, while the R1, 46.6% strains presented 
the genotype mecA+/ PVL-/ clfA-/ fnbB- with more isolates in wound. (Table 2). 
 
Table 2 - Relationship between antimicrobial resistance profile, isolation site and resistance and virulence profile of the clinical samples of sensitive and resistant Staphylococcus aureus and infection episodes used in the study.
CLI, Clindamycin; ERY, Erythromycin; RIF, Rifampicin; PEN, Penicillin; MET, Meticiline; TET, Tetracycline; AMI, Amicacina; CIP, Ciprofloxacin; NE, Not evaluated
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The table 3 shows the risk factors for Staphylococcus aureus infections. Although only the result of 
avera ge age presents significance, on what patients with MRSA had a mean age of 61.1 years and with 
MSSA, 37.7 years, other results showed important percentage differences. The majority of patients with 
resistant infection had ICU hospitalization (53.8%), made use of the inappropriate antibiotic therapy 
(50.0%) and used central venous catheter (61.5%), while the use of mechanical ventilation was higher in 
patients with sensitive infection (75.8%). The average hospitalization time and the average hospitalization 
time until diagnostic was also higher in patients with MRSA infection (44.5 days and 25.8 days, respectively).
 
Table 03 - Risk factors for Staphylococcus aureus with the resistance and sensitive phenotypes of hospi-
talized between November/2015 and April/2016.
   SD, Standart deviation; ICU, Intensive-care unit; CVC, Central venous catheter; MV, Mechanical ventilation
   *50.0% MRSA
Analyzing and determining the importance of MRSA in research-limited countries is a great challenge, 
since today the study has demonstrated a more significant prevalence of Gram-negative bacilli as etiology 
of infections. However, our results agree with previous studies reporting a high burden of this phenotype 
among Staphylococcus aureus infection (ENRIGHT; ROBINSON; RANDLE, et al. 2002; WORLD 
HEALTH ORGANIZATION, 2015; FRIEDRICH, 2019).
Interestingly, in our assessment, MSSA was responsible for 33.3% of pneumonia and MRSA was 
predominant of bloodstream infection. Special attention was given to the Gram-negative bacilli, the main 
cause of pneumonia and urinary tract infection. This is particularly worrisome, since the literature shows 
that therapeutic options are scarce or ineffective to the multidrug-resistant organisms (ZARAGOZA; 
ARTERO; CAMARENA, et al. 2003; BASETTI; POULAKOU; RUPPE, et al. 2017). 
MRSA is a well-recognized public health problem through the world (CIMOLAI, 2007; STRUELENS, 
2009; CHESSA; HANAU; MAZZARELLO, 2015). From a hospital perspective, patients with MRSA tendent 
to be older, to have a longer hospital stay, to have a recent background of hospitalization, among others. 
The present study has detected and considered such factors, in which the patients with MRSA infection 
were significantly older and were hospitalized 17 days longer than those with MSSA infection, as well as 
in previous hospitalizations when the same comparison was made. 
Empirical antibiotic therapy may appear to be a good treatment strategy before the microbiological 
result is available, however, as an inappropriate therapy can lead to increased antibiotic resistance (ZHANG; 
MICEK; KOLLEF, 2015; YOON; PARK; SOHN, et al. 2016). This phenomenon is more marked in countries 
where the level of consumption and antimicrobial resistance are higher and where multidrug-resistant 
pathogens spread rapidly (CIORBA; ODONE; VERONESI, et al. 2015; BRAGA; CAMPOS; BATISTÃO, 
et al. 2019). In our surveillance, 50.0% of patients with MRSA infection received inappropriate antibiotic 
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therapy. The literature shows that the delay in initiating appropriate therapy may lead to a higher mortality 
rate (WI; RHEE; KANG, et al. 2018). Due to the small number of patients, the data collected in this study 
did not allow the specific examination of the effect of appropriate antibiotic therapy. However, knowing 
the prescribing patterns of antibiotics for S. aureus infections in our institution, may justify the results of 
similar mortality rates between MRSA and MSSA in our cohort, which leads us to assume that empirical 
antibiotic therapy may have been more effective against MRSA during the study period.
S. aureus is also a versatile pathogen in the production of several types of virulence factors, with the 
objective of destroying the host cells and causing infections in different ways (FOSTER; GEOGHEGAN; 
GANESH, et al. 2013; OTTO, 2014; WI; RHEE; KANG, et al. 2018; JIANG; YIN; YOU, 2018). Although 
our sample size was small, we found important virulence factors associated with MRSA. The fnbB genes 
responsible for binder production of fribronectin and clfA (POWERS; WARDENBURG, 2014), responsible 
for cloning factor encoding were positive in 8.8% and 44.1%, respectively, in MRSA strains. The lukS, 
responsible for the production of the PVL toxin was not present in any of the strains evaluated (MORAN; 
KRISHNADASAN; GORWITZ, et al. 2006), this should be found to be more prevalent in community strains. 
In conclusion, although Gram-negative bacilli are predominant in nosocomial infections in Brazil, 
Staphylococcus aureus, particularly those resistant and more virulent, is still present in the hospital 
environment in important frequencies especially in ICU. Our further results confirm previous report 
showing a high frequency of inappropriate antibiotic therapy among MRSA associated with a very long 
hospitalization time.
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